Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis. [Phase 3]

View source ↗

Summary

A Phase III multicenter, randomized, double-blind, placebo-controlled trial will evaluate the efficacy and safety of RSS0393 ointment in adults with plaque psor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSS0393 Ointment

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Plaque Psoriasis Subjects | Phase 3 | Status: NOT_YET_RECRUITING